Jubilant Pharmova posts 14% FY26 revenue growth to Rs. 8,280 crore amid margin pressure
Q4FY26 revenue climbs 19% to Rs. 2,290 crore as CDMO sterile injectables, radiopharma and generics businesses drive growth momentum
Q4FY26 revenue climbs 19% to Rs. 2,290 crore as CDMO sterile injectables, radiopharma and generics businesses drive growth momentum
The ruling brings closure to a nearly decade-long investigation into hospital operations and healthcare delivery practices
Combined platform with 55+ centres aims to expand integrated maternity, fertility, neonatal and paediatric care across India
All three dose levels, 4 mg, 9 mg and 12 mg, successfully met the primary and key secondary endpoints in 80 weeks
The company’s revenue stood at Rs. 287.68 crore, reflecting a 4.7 percent increase over Rs. 274.71 crore reported in FY25
Sheshadri brings with him extensive leadership experience spanning healthcare, diagnostics, telecom, and consumer goods industries
By leveraging digital screening and remote consultation, the medical community is moving beyond the confines of the clinic
She brings extensive expertise in managing global and domestic procurement operations
Combined footprint expands to 420 hearing care centres across India
Subscribe To Our Newsletter & Stay Updated